124 related articles for article (PubMed ID: 10573477)
21. Haemolytic anaemia associated with high dose intravenous immunoglobulin therapy in a child with Guillain-Barré syndrome.
Trifa M; Simon L; Hamza J; Bavoux F; des Roziers NB
Arch Dis Child; 2003 Sep; 88(9):836-7. PubMed ID: 12937119
[No Abstract] [Full Text] [Related]
22. Respiratory distress.
Kannikeswaran N; Mahajan PV
Clin Pediatr (Phila); 2005 Apr; 44(3):275-8. PubMed ID: 15821856
[No Abstract] [Full Text] [Related]
23. Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome.
Mehndiratta MM; Chowdhury D; Goel V
J Assoc Physicians India; 2001 Apr; 49():459-69. PubMed ID: 11762620
[No Abstract] [Full Text] [Related]
24. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
Koichihara R; Hamano S; Yamashita S; Tanaka M
Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
[TBL] [Abstract][Full Text] [Related]
25. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
[No Abstract] [Full Text] [Related]
26. Intravenous immunoglobulin responsive gastroparesis in a patient with diabetes mellitus.
Xu S; Inchley F; Nye E; Tan CY; Renouf D
Intern Med J; 2019 Nov; 49(11):1455-1456. PubMed ID: 31713331
[No Abstract] [Full Text] [Related]
27. Treatment of Guillain-Barré syndrome with corticosteroids: lack of benefit?
Hughes RA
Lancet; 2004 Jan; 363(9404):181-2. PubMed ID: 14738786
[No Abstract] [Full Text] [Related]
28. Guillain-Barré syndrome following chickenpox: a case series.
Tatarelli P; Garnero M; Del Bono V; Camera M; Schenone A; Grandis M; Benedetti L; Viscoli C
Int J Neurosci; 2016; 126(5):478-9. PubMed ID: 26000930
[TBL] [Abstract][Full Text] [Related]
29. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
Korinthenberg R; Schessl J; Kirschner J; Mönting JS
Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
[TBL] [Abstract][Full Text] [Related]
30. Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome.
Uygur Kucukseymen E; Yuksel B; Genc F; Ozaydin Goksu E; Yildiz S; Bicer Gomceli Y
Clin Neuropharmacol; 2017; 40(5):224-225. PubMed ID: 28816832
[TBL] [Abstract][Full Text] [Related]
31. Steroids in the Guillain-Barré syndrome: is there a therapeutic window?
Van Koningsveld R; Van Doorn PA
Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470
[No Abstract] [Full Text] [Related]
32. Pharyngeal-cervical-brachial variant of pediatric Guillain-Barré syndrome with antecedent acute hepatitis A virus infection.
Thapa R; Biswas B; Mallick D; Mukherjee S
J Child Neurol; 2009 Jul; 24(7):865-7. PubMed ID: 19295182
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin for Guillain-Barré syndrome: how effective?
Tasdemir HA; Dilber C; Kanber Y; Uysal S
J Child Neurol; 2006 Nov; 21(11):972-4. PubMed ID: 17092465
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effect of interferon and adrenal hormone for children with Guillain-Barre syndrome].
Yang XM; Zheng P; Haier NS
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Mar; 15(3):153. PubMed ID: 12831618
[No Abstract] [Full Text] [Related]
35. Blockade of blocking antibodies in Guillain-Barré syndromes: "unblocking" the mystery of action of intravenous immunoglobulin.
Dalakas MC
Ann Neurol; 2002 Jun; 51(6):667-9. PubMed ID: 12112069
[No Abstract] [Full Text] [Related]
36. [Guillain-Barre syndrome in children in 2009-2014 years].
Stasiak K; Wesołowska E; Kroczka S
Przegl Lek; 2016; 73(3):167-9. PubMed ID: 27349047
[TBL] [Abstract][Full Text] [Related]
37. Guillain-Barré syndrome (demyelinating) six weeks after bariatric surgery: A case report and literature review.
Ishaque N; Khealani BA; Shariff AH; Wasay M
Obes Res Clin Pract; 2015; 9(4):416-9. PubMed ID: 25765350
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of Guillain-Barré Syndrome].
Nomura K
Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
[TBL] [Abstract][Full Text] [Related]
39. [Clinical picture, evolution and results of treatment of Guillain-Barré syndrome in children and adolescents].
Zielińska M; Galas-Zgorzalewicz B
Neurol Neurochir Pol; 2000; 34(3 Suppl):27-40. PubMed ID: 10983298
[TBL] [Abstract][Full Text] [Related]
40. [Combination therapy with methylprednisolone (mPSL) and high-dose immunoglobulin (IVIg)].
Nishida H; Kuroda T; Wakita K
Nihon Rinsho; 2008 Jun; 66(6):1190-4. PubMed ID: 18540369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
